DuPont de Nemours (NYSE:DD – Get Free Report) issued an update on its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 7.020-7.160 for the period, compared to the consensus estimate of 7.170. The company issued revenue guidance of -. DuPont de Nemours also updated its Q2 2026 guidance to 1.750-1.750 EPS.
DuPont de Nemours Trading Down 1.8%
DD opened at $137.48 on Thursday. The firm’s fifty day simple moving average is $143.01 and its 200 day simple moving average is $137.62. The stock has a market capitalization of $55.69 billion, a P/E ratio of -2,290.92, a P/E/G ratio of 1.33 and a beta of 1.03. The company has a current ratio of 2.68, a quick ratio of 2.11 and a debt-to-equity ratio of 0.22. DuPont de Nemours has a 12 month low of $84.75 and a 12 month high of $157.98.
DuPont de Nemours (NYSE:DD – Get Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The basic materials company reported $0.55 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.07. DuPont de Nemours had a negative net margin of 0.30% and a positive return on equity of 7.15%. The company had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same period last year, the business earned $3.09 EPS. The business’s quarterly revenue was up 4.3% on a year-over-year basis. DuPont de Nemours has set its Q2 2026 guidance at 0.590-0.590 EPS and its FY 2026 guidance at 2.350-2.400 EPS. As a group, research analysts anticipate that DuPont de Nemours will post 2.38 EPS for the current fiscal year.
DuPont de Nemours Cuts Dividend
Analyst Upgrades and Downgrades
DD has been the subject of a number of research reports. Weiss Ratings raised shares of DuPont de Nemours from a “sell (d)” rating to a “sell (d+)” rating in a report on Wednesday, May 6th. The Goldman Sachs Group initiated coverage on DuPont de Nemours in a research report on Monday, June 15th. They set a “neutral” rating and a $159.00 price objective on the stock. Citigroup lowered their price objective on DuPont de Nemours from $177.00 to $168.00 and set a “buy” rating for the company in a research note on Monday, April 13th. Royal Bank Of Canada raised their price target on shares of DuPont de Nemours from $168.00 to $180.00 and gave the company an “outperform” rating in a research report on Monday, May 11th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on DuPont de Nemours from $174.00 to $180.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, DuPont de Nemours currently has a consensus rating of “Moderate Buy” and a consensus price target of $165.20.
Institutional Investors Weigh In On DuPont de Nemours
Large investors have recently bought and sold shares of the company. Palisade Asset Management LLC purchased a new position in DuPont de Nemours during the third quarter worth about $26,000. Imprint Wealth LLC acquired a new stake in shares of DuPont de Nemours during the 3rd quarter worth $27,000. Measured Wealth Private Client Group LLC acquired a new stake in shares of DuPont de Nemours during the third quarter worth $30,000. Atlas Capital Advisors Inc. bought a new position in shares of DuPont de Nemours in the 4th quarter worth about $38,000. Finally, Ameriflex Group Inc. boosted its holdings in shares of DuPont de Nemours by 5,940.0% in the 4th quarter. Ameriflex Group Inc. now owns 1,208 shares of the basic materials company’s stock valued at $49,000 after buying an additional 1,188 shares during the period. 73.96% of the stock is currently owned by hedge funds and other institutional investors.
About DuPont de Nemours
DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.
DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.
Recommended Stories
- Five stocks we like better than DuPont de Nemours
- Washington’s Quantum Push Puts IBM and IonQ on the Throne
- FedEx’s Earnings Drop May Be Missing the Bigger Freight Story
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.
